Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559349 · ClinicalTrials.gov registry record
Gut Microbiota And Radiotherapy
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 10
- Enrollment target
NCT02559349: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT02559349 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02559349 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
A pilot, single arm, single center study to determine the feasibility of obtaining stool samples from adult patients receiving SBRT to a lung tumor, if SBRT induces changes in the gut microbiota and to obtain preliminary data about possible correlation of baseline composition and changes in gut microbiota with tumor response, local control, and development of pneumonitis/other side effects.
Interventions
- OTHER Stool Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-12 |
What the finished NCT02559349 record still lists
NCT02559349 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Stool Collection is the first listed.
NCT02559349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02559349 about?
NCT02559349 is a clinical study titled "Gut Microbiota And Radiotherapy". A pilot, single arm, single center study to determine the feasibility of obtaining stool samples from adult patients receiving SBRT to a lung tumor, if SBRT induces changes in the gut microbiota and to obtain preliminary data about possible correlation of baseline composition and changes in gut micr...
What is the current status of trial NCT02559349?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2015-09. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02559349?
The interventions under investigation include: Stool Collection (OTHER).
Who is sponsoring clinical trial NCT02559349?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia